Explore more publications!
St. Vincent & Grenadines Health Press
Got News to Share?

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 7, 2026

Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
Apr. 7, 2026

Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

Indeterminate GlobeNewswire
Route 92 Medical Announces $50 Million Growth Financing
Apr. 7, 2026

Route 92 Medical Announces $50 Million Growth Financing

Indeterminate GlobeNewswire
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
Apr. 7, 2026

Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium

Indeterminate GlobeNewswire
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Apr. 7, 2026

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Indeterminate GlobeNewswire
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Apr. 7, 2026

Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy

Indeterminate GlobeNewswire
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Apr. 7, 2026

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer

Indeterminate GlobeNewswire
Liquidia Corporation to Participate in Upcoming Investor Conferences
Apr. 7, 2026

Liquidia Corporation to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
Apr. 7, 2026

electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

Indeterminate GlobeNewswire
Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board
Apr. 7, 2026

Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board

Indeterminate GlobeNewswire
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement
Apr. 7, 2026

Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement

Indeterminate GlobeNewswire
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements
Apr. 7, 2026

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

Indeterminate GlobeNewswire
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
Apr. 7, 2026

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Indeterminate GlobeNewswire
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr. 7, 2026

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions
Apr. 7, 2026

Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions

Indeterminate GlobeNewswire
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
Apr. 7, 2026

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

Indeterminate GlobeNewswire
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
Apr. 7, 2026

Cognition Therapeutics to Present at Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Apr. 7, 2026

Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales

Indeterminate GlobeNewswire
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
Apr. 7, 2026

CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

Indeterminate GlobeNewswire
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
Apr. 7, 2026

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

Indeterminate GlobeNewswire
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Apr. 7, 2026

Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions